Jump to navigation
Dear Mr. White, We are writing to you to express our concern about the lack of availability in developing countries of the new melt extrusion (Meltrex) formulation of lopinavir/ritonavir (LPV/r), marketed as Kaletra (200/50mg tablets).
A Statement Delivered by Helen O'Neill, Deputy Director of Operations, Médecins Sans Frontières (MSF) at the United Nations Security Council "Arria Formula" meeting
333 7th Avenue, New York, NY 10001-5004
A 501(c)(3) tax-exempt organization. Federal Identification Number (EIN): 13-3433452.